Combined clinical, histological and stereomorphometric studies with a new oral contraceptive of normophasic type: Fysioquens.
D000328:Adult; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000008:administration & dosage*; D003279:Contraceptives, Oral, Sequential / Q000008:administration & dosage* / Q000009:adverse effects; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000008:administration & dosage* / Q000009:adverse effects
D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D004997:Ethinyl Estradiol; D008234:Lynestrenol